1. The Role of Chemotherapy in Improving Quality of Life in Advanced NSCLC

2. Program Goals

3. Introduction

4. Assessing Health-Related QoL in Advanced NSCLC

5. Chemotherapy + Supportive Care vs Supportive Care Alone in Advanced NSCLC

6. Symptom Control / Relief Impact on QoL in Advanced NSCLC

7. Individualized Chemotherapy Selection

8. Cisplatin vs Carboplatin

9. Effective Management of Chemotherapy-induced Nausea and Vomiting Associated With Platinum Agents

12. Individualizing Chemotherapy Selection PointBreak Trial: Safety Results

13. Nab-paclitaxel vs Solvent-based Paclitaxel in First-line Chemotherapy Trial Design

14. Nab-paclitaxel vs Solvent-based Paclitaxel in First-line Chemotherapy Efficacy Results

15. Nab-paclitaxel vs Solvent-based Paclitaxel in First-line Chemotherapy Safety Results

16. Impact of Palliative Care in Advanced NSCLC

17. Depression in Advanced NSCLC

18. Other Interventions

19. Other Interventions (cont)

20. Summary

21. Abbreviations

22. Abbreviations (cont)

23. References

24. References (cont)

25. References (cont)

26. References (cont)

27. References (cont)

28. References (cont)

29. References (cont)

30. References (cont)